127 related articles for article (PubMed ID: 9933433)
1. Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system.
Aukrust P; Müller F; Svenson M; Nordøy I; Bendtzen K; Frøland SS
Clin Exp Immunol; 1999 Jan; 115(1):136-43. PubMed ID: 9933433
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy.
Kumari S; Bhol KC; Rehman F; Foster CS; Ahmed AR
Cytokine; 2001 May; 14(4):218-24. PubMed ID: 11448121
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
[TBL] [Abstract][Full Text] [Related]
4. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.
Aukrust P; Frøland SS; Liabakk NB; Müller F; Nordøy I; Haug C; Espevik T
Blood; 1994 Oct; 84(7):2136-43. PubMed ID: 7919327
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
7. Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia.
Ibáñez C; Suñé P; Fierro A; Rodríguez S; López M; Alvarez A; De Gracia J; Montoro JB
BioDrugs; 2005; 19(1):59-65. PubMed ID: 15691218
[TBL] [Abstract][Full Text] [Related]
8. IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence.
Andersen LS; Petersen J; Svenson M; Bendtzen K
Autoimmunity; 1995; 22(2):127-33. PubMed ID: 8722583
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.
Aukrust P; Hestdal K; Lien E; Bjerkeli V; Nordøy I; Espevik T; Müller F; Frøland SS
J Infect Dis; 1997 Oct; 176(4):913-23. PubMed ID: 9333149
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
[TBL] [Abstract][Full Text] [Related]
11. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.
Wu KH; Wu WM; Lu MY; Chiang BL
Pediatr Allergy Immunol; 2006 Feb; 17(1):60-8. PubMed ID: 16426257
[TBL] [Abstract][Full Text] [Related]
13. IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location.
Jablonska E; Jablonski J; Piotrowski L; Grabowska Z
Immunobiology; 2001 Dec; 204(4):508-16. PubMed ID: 11776404
[TBL] [Abstract][Full Text] [Related]
14. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo.
Aukrust P; Müller F; Nordøy I; Haug CJ; Frøland SS
Clin Exp Immunol; 1997 Jan; 107(1):50-6. PubMed ID: 9010256
[TBL] [Abstract][Full Text] [Related]
15. Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
Schwaighofer H; Oberhuber G; Hebart H; Einsele H; Herold M; Nachbaur D; Eibl B; Tilg H; Kropshofer G; Ferrara JL; Niederwieser D
Transplantation; 1997 Jan; 63(1):52-6. PubMed ID: 9000660
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
[TBL] [Abstract][Full Text] [Related]
17. Autologous serum deprivation restored IL-1 receptor antagonist production by peripheral blood mononuclear cells in patients with gastric cancer.
Shimamura H; Iwagaki H; Gouchi A; Morimoto Y; Ariki N; Funaki M; Tanaka N
J Int Med Res; 2000; 28(6):277-87. PubMed ID: 11191721
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
[TBL] [Abstract][Full Text] [Related]
19. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
20. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.
Takeda Y; Hiraishi K; Takeda H; Shiobara N; Shibusawa H; Saniabadi AR; Adachi M; Kawata S
Inflamm Res; 2003 Jun; 52(7):287-90. PubMed ID: 12861393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
